The Goldwater Institute’s Brian Norman Discusses Right to Try 2.0 and Patient Access to Treatments — Health Policy Podcast

Brian Norman, Director of State Affairs at The Goldwater Institute, discusses the importance of Right to Try 2.0 in improving patient access to treatments, healthcare regulation, and individual liberty. Key topics include the drug approval process and the need for timely access to individualized treatments for rare diseases.

WASHINGTON — May 25, 2026 — Brian Norman of The Goldwater Institute appeared on the Health Policy Podcast to discuss Right to Try 2.0 and its implications for patient access to treatments. The episode covers the challenges of healthcare regulation, the drug approval process, and the importance of individual liberty in medical decision-making.

In the podcast, Norman emphasizes the obstacles posed by government interventions in healthcare. He stated, "There are a myriad of government interventions that interfere with free markets when it comes to healthcare and also interfere with the ability for individuals to make their own healthcare decisions." He advocates for a regulatory pathway that allows patients with rare diseases to access individualized treatments more efficiently.

Norman also highlights the urgency of reform, noting, "In the United States of America, we are falling behind other countries... getting these individualized treatments to market." He shares the story of the Riley family, whose daughters suffer from a rare genetic condition. The family had to relocate to Italy to access a treatment not available in the U.S., illustrating the need for Right to Try 2.0. "The story of the Riley family is the perfect illustration of why Right to Try 2.0 is necessary," he said.

The Goldwater Institute is a free-market think tank and public interest litigation firm dedicated to advancing individual liberty through research and advocacy on a variety of public policy issues.

About the Health Policy Podcast

The Health Policy Podcast focuses on energy, infrastructure, policy, and economic growth, providing insights and discussions on critical health policy issues affecting individuals and communities.